The neonatal point of care testing market size has grown rapidly in recent years. It will grow from $1.32 billion in 2025 to $1.52 billion in 2026 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing neonatal mortality awareness, adoption of rapid testing devices in hospitals, government support for neonatal care, expansion of maternity clinics, technological improvements in bedside testing.
The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.59 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to rise of AI-based diagnostic solutions, cloud integration for neonatal data management, portable and compact point-of-care devices, increasing private-public partnerships in newborn health, growth in emerging economies’ neonatal healthcare infrastructure. Major trends in the forecast period include AI-enabled neonatal diagnostics, cloud-based point-of-care platforms, portable testing devices, real-time data analysis, integration of IoT for newborn monitoring.
The rising demand for remote patient monitoring is anticipated to drive the growth of the neonatal point-of-care testing market in the coming years. Remote patient monitoring involves delivering healthcare services through technology that connects patients and healthcare professionals remotely. The increasing demand for remote patient monitoring is driven by the growing need for accessible and convenient healthcare, particularly for patients in remote or underserved regions. Neonatal point-of-care testing supports remote patient monitoring by offering rapid bedside diagnostic results, enabling healthcare providers to promptly detect and manage critical conditions in newborns without dependence on centralized laboratories. For example, in August 2023, according to Vivalink, a US-based healthcare technology company, a recent survey found that 84% of existing remote patient monitoring (RPM) users plan to expand their use in 2024, 45% of healthcare providers are applying RPM for acute monitoring in hospital-at-home programs, and 77% believe RPM-based care will surpass traditional inpatient hospital care within the next five years. Consequently, the growing demand for remote patient monitoring is expected to fuel the growth of the neonatal point-of-care testing market.
Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.
In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company’s growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl.
North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neonatal point of care testing market by increasing the cost of imported instruments, reagents, and kits. This has slowed adoption in hospitals and maternity clinics in regions such as Asia-Pacific and Europe. Instruments like blood gas analyzers and bilirubinometers are most impacted. Positive impacts include encouragement of local manufacturing and domestic reagent production, which improves supply chain resilience and lowers long-term operational costs.
The neonatal point of care testing market research report is one of a series of new reports that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.
The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.
The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neonatal point of care testing market size is expected to see rapid growth in the next few years. It will grow to $2.59 billion in 2030 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to rise of AI-based diagnostic solutions, cloud integration for neonatal data management, portable and compact point-of-care devices, increasing private-public partnerships in newborn health, growth in emerging economies’ neonatal healthcare infrastructure. Major trends in the forecast period include AI-enabled neonatal diagnostics, cloud-based point-of-care platforms, portable testing devices, real-time data analysis, integration of IoT for newborn monitoring.
The rising demand for remote patient monitoring is anticipated to drive the growth of the neonatal point-of-care testing market in the coming years. Remote patient monitoring involves delivering healthcare services through technology that connects patients and healthcare professionals remotely. The increasing demand for remote patient monitoring is driven by the growing need for accessible and convenient healthcare, particularly for patients in remote or underserved regions. Neonatal point-of-care testing supports remote patient monitoring by offering rapid bedside diagnostic results, enabling healthcare providers to promptly detect and manage critical conditions in newborns without dependence on centralized laboratories. For example, in August 2023, according to Vivalink, a US-based healthcare technology company, a recent survey found that 84% of existing remote patient monitoring (RPM) users plan to expand their use in 2024, 45% of healthcare providers are applying RPM for acute monitoring in hospital-at-home programs, and 77% believe RPM-based care will surpass traditional inpatient hospital care within the next five years. Consequently, the growing demand for remote patient monitoring is expected to fuel the growth of the neonatal point-of-care testing market.
Leading companies in the neonatal point of care testing market are forming strategic collaborations to expand access to diagnostics and improve early healthcare for newborns. Strategic collaborations involve partnerships between organizations that combine their resources and expertise to reach shared objectives. For example, in January 2025, QIAGEN, a provider of sample and assay technologies based in the Netherlands, entered a partnership with Genomics England, a genomic medicine organization located in the United Kingdom. This collaboration supported the launch of the Generation Study, a project aimed at sequencing the genomes of one hundred thousand newborns in England to identify more than two hundred treatable genetic conditions. QIAGEN is contributing clinically relevant genetic variant data for the genes assessed in the point of care sequencing test, enabling faster analysis and reporting of results. The study officially began in October 2024 and is expected to impact the early detection and treatment of conditions affecting approximately three thousand newborns each year in the United Kingdom.
In March 2025, LaCAR MDx Technologies, a biotechnology company based in Belgium, acquired the newborn screening division of Baebies Incorporated for an undisclosed amount. This acquisition expands LaCAR's portfolio by increasing the range of neonatal diagnostic solutions it can offer and supports the company’s growth in the United States market. Baebies Incorporated is a company based in the United States that specializes in neonatal point of care testing.
Major companies operating in the neonatal point of care testing market are Abbott Laboratories, Siemens Healthineers AG, GE Healthcare Technologies Inc., Koninklijke Philips N.V., Roche Diagnostics International AG, Danaher Corporation, Dräger AG & Co. KGaA, Masimo Corporation, Radiometer Medical ApS, Nova Biomedical Corporation, bioMérieux SA, Sysmex Corporation, Nihon Kohden Corporation, Natus Medical Incorporated, Contec Medical Systems Co. Ltd., Edan Instruments Inc., Trivitron Healthcare, Bistos Co. Ltd., Bilimetrix S.r.l., GINEVRI Srl.
North America was the largest region in the neonatal point of care testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neonatal point of care testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neonatal point of care testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neonatal point of care testing market by increasing the cost of imported instruments, reagents, and kits. This has slowed adoption in hospitals and maternity clinics in regions such as Asia-Pacific and Europe. Instruments like blood gas analyzers and bilirubinometers are most impacted. Positive impacts include encouragement of local manufacturing and domestic reagent production, which improves supply chain resilience and lowers long-term operational costs.
The neonatal point of care testing market research report is one of a series of new reports that provides neonatal point of care testing market statistics, including neonatal point of care testing industry global market size, regional shares, competitors with a neonatal point of care testing market share, detailed neonatal point of care testing market segments, market trends and opportunities, and any further data you may need to thrive in the neonatal point of care testing industry. This neonatal point of care testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neonatal point-of-care testing is the practice of performing diagnostic evaluations near the location where newborns receive care. It provides immediate clinical information, enabling rapid and informed decision-making. This approach delivers timely and accurate results while reducing the delays and logistical challenges associated with traditional laboratory testing.
The primary products in neonatal point-of-care testing include instruments and assays. Instruments consist of portable analyzers, handheld readers, and bedside monitors used to assess newborn health directly in care settings. Test types include neonatal bilirubin testing, newborn metabolic screening, blood glucose testing, infectious disease screening, electrolyte testing, and others. Key end-users include hospitals, diagnostic centers, maternity and specialty clinics, and additional healthcare facilities.
The neonatal point of care testing market consists of revenues earned by entities by providing services such as rapid diagnostic screening, blood gas and electrolyte analysis, glucose level monitoring, and sepsis detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The neonatal point of care testing market also includes sales of portable diagnostic analyzers, oxygen saturation monitors, hematology analyzers, and lactate analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neonatal Point of Care Testing Market Characteristics
3. Neonatal Point of Care Testing Market Supply Chain Analysis
4. Global Neonatal Point of Care Testing Market Trends and Strategies
5. Neonatal Point of Care Testing Market Analysis of End Use Industries
7. Global Neonatal Point of Care Testing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neonatal Point of Care Testing Total Addressable Market (TAM) Analysis for the Market
9. Neonatal Point of Care Testing Market Segmentation
10. Neonatal Point of Care Testing Market Regional and Country Analysis
11. Asia-Pacific Neonatal Point of Care Testing Market
12. China Neonatal Point of Care Testing Market
13. India Neonatal Point of Care Testing Market
14. Japan Neonatal Point of Care Testing Market
15. Australia Neonatal Point of Care Testing Market
16. Indonesia Neonatal Point of Care Testing Market
17. South Korea Neonatal Point of Care Testing Market
18. Taiwan Neonatal Point of Care Testing Market
19. South East Asia Neonatal Point of Care Testing Market
20. Western Europe Neonatal Point of Care Testing Market
21. UK Neonatal Point of Care Testing Market
22. Germany Neonatal Point of Care Testing Market
23. France Neonatal Point of Care Testing Market
24. Italy Neonatal Point of Care Testing Market
25. Spain Neonatal Point of Care Testing Market
26. Eastern Europe Neonatal Point of Care Testing Market
27. Russia Neonatal Point of Care Testing Market
28. North America Neonatal Point of Care Testing Market
29. USA Neonatal Point of Care Testing Market
30. Canada Neonatal Point of Care Testing Market
31. South America Neonatal Point of Care Testing Market
32. Brazil Neonatal Point of Care Testing Market
33. Middle East Neonatal Point of Care Testing Market
34. Africa Neonatal Point of Care Testing Market
36. Neonatal Point of Care Testing Market Competitive Landscape and Company Profiles
37. Neonatal Point of Care Testing Market Other Major and Innovative Companies
40. Neonatal Point of Care Testing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Neonatal Point Of Care Testing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neonatal point of care testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neonatal point of care testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neonatal point of care testing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Assay2) By Test Type: Neonatal Bilirubin Testing; Blood Glucose Testing; Infectious Disease Screening; Electrolyte Testing; Other Test Types
3) By End-Users: Hospitals; Maternity And Specialty Clinics; Other End-Users
Subsegments:
1) By Instruments: Blood Gas Analyzers; Bilirubinometers; Glucose Meters2) By Assay: Bilirubin Assays; Glucose Assays; Infectious Disease Assays; Electrolyte Assays; Blood Gas Assays
Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; GE Healthcare Technologies Inc.; Koninklijke Philips N.V.; Roche Diagnostics International AG; Danaher Corporation; Dräger AG & Co. KGaA; Masimo Corporation; Radiometer Medical ApS; Nova Biomedical Corporation; bioMérieux SA; Sysmex Corporation; Nihon Kohden Corporation; Natus Medical Incorporated; Contec Medical Systems Co. Ltd.; Edan Instruments Inc.; Trivitron Healthcare; Bistos Co. Ltd.; Bilimetrix S.r.l.; GINEVRI Srl
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neonatal Point of Care Testing market report include:- Abbott Laboratories
- Siemens Healthineers AG
- GE Healthcare Technologies Inc.
- Koninklijke Philips N.V.
- Roche Diagnostics International AG
- Danaher Corporation
- Dräger AG & Co. KGaA
- Masimo Corporation
- Radiometer Medical ApS
- Nova Biomedical Corporation
- bioMérieux SA
- Sysmex Corporation
- Nihon Kohden Corporation
- Natus Medical Incorporated
- Contec Medical Systems Co. Ltd.
- Edan Instruments Inc.
- Trivitron Healthcare
- Bistos Co. Ltd.
- Bilimetrix S.r.l.
- GINEVRI Srl
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.52 Billion |
| Forecasted Market Value ( USD | $ 2.59 Billion |
| Compound Annual Growth Rate | 14.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
